When ROS accumulate excessively, cancer cells in response, enhanced antioxidant systems, such as superoxide dismutase (SOD) and catalase, to counteract the ROS-generated cytotoxicity, thus inhibiting their antioxidant capacity in the later stage of tumor progression, have been proposed as an approach for cancer therapy [14,15]. This evidence concerns the gene CAT and cancer.